Worth reading
40Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
66
¥100 million (year-on-year increase in operating income)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationSecond quarter of the fiscal year ending March 20278 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥934 100 million
Operating profit¥24 100 million
Ordinary income¥58 100 million
Net income¥44 100 million
Gross Profit Margin15.8%
Operating profit margin2.7%
Selling, general and administrative expenses¥123 100 million
Full-year earnings forecast
Net Sales
¥1,900 100 million
Gross profit
¥280 100 million
Selling, general and administrative expenses
¥250 100 million
Operating profit
¥30 100 million
Non-Operating Gains and Losses
¥45 100 million
Ordinary income
¥75 100 million
Corporate income taxes
¥15 100 million
Net income attributable to owners of the parent
¥60 100 million
Orders received
¥2,000 100 million
Orders received, including equity-method investments
¥2,000 100 million
Year-end dividend
¥25
Net assets
¥497 100 million
ROE
12.9%
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales49%
Gross profit53%
Selling, general and administrative expenses49%
Operating profit80%
Non-Operating Gains and Losses76%
Ordinary income77%
Corporate income taxes93%
Net income attributable to owners of the parent73%
Orders received53%
Orders received, including equity-method investments59%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing at a pace above the period progress rate at each profit levelBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating CF
Reversal of the positive result in the previous fiscal year¥-60 100 million
Investing CF
Decrease in time deposits¥63 100 million
Financing CF
Repayment of borrowings¥-197 100 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rateUS$1=¥150
Key KPIsA metric the company considers important as a management benchmark.
- Orders received¥1,065 100 millionYear on year against the same period last year-¥21.2 billion
- Orders received, including equity-method investments¥1,170 100 millionYear on year against the same period last year-¥247.1 billion
- Order backlog¥2,811 100 millionYear on year against the same period last year-¥46.4 billion
- Order backlog, including equity-method affiliates¥4,550 100 millionYear on year against the same period last year-¥158.9 billion
- Equity ratio20.0%Year on year against the same period last year+3.3 percentage points
- Debt-to-equity ratio0.9 TimesYear on year against the same period last year-0.12x
Segment results
Region
Japan269
Southeast Asia and South Korea309
Southwest Asia, the Middle East and Africa197
Russia and Central Asia15
North America62
Central and South America12
China68
Other2
Products
Petrochemicals274
Oil and Gas152
Power Generation, etc.123
Chemicals and Fertilizers263
Pharmaceuticals, Environment and Industrial Facilities101
Other21
Financial targets
ROE12.9% (forecast for the fiscal year ending March 2027)
Debt-to-equity ratio0.90x (actual as of September 2026)
Equity ratio20.0% (actual as of September 2026)
Orders received and order backlog
Orders received¥1,065 100 million
Order backlog¥2,811 100 million
Orders received, including equity-method investments¥1,170 100 million
Order backlog, including equity-method affiliates¥4,550 100 million
Annual Dividend
Annual¥25
Interim¥0
End of period¥25
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥934 100 million |
| Operating profit | ¥24 100 million |
| Ordinary income | ¥58 100 million |
| Net income | ¥44 100 million |
| Gross Profit Margin | 15.8% |
| Operating profit margin | 2.7% |
| Selling, general and administrative expenses | ¥123 100 million |
| Full-year earnings forecast | Net Sales ¥1,900 100 million / Gross profit ¥280 100 million / Selling, general and administrative expenses ¥250 100 million / Operating profit ¥30 100 million / Non-Operating Gains and Losses ¥45 100 million / Ordinary income ¥75 100 million / Corporate income taxes ¥15 100 million / Net income attributable to owners of the parent ¥60 100 million / Orders received ¥2,000 100 million / Orders received, including equity-method investments ¥2,000 100 million / Year-end dividend ¥25 / Net assets ¥497 100 million / ROE 12.9% |
| Progress against full-year forecast | Net Sales 49% / Gross profit 53% / Selling, general and administrative expenses 49% / Operating profit 80% / Non-Operating Gains and Losses 76% / Ordinary income 77% / Corporate income taxes 93% / Net income attributable to owners of the parent 73% / Orders received 53% / Orders received, including equity-method investments 59% |
| Self-assessment against the plan | Progressing at a pace above the period progress rate at each profit level |
| Segment results | Region Japan 269 / Southeast Asia and South Korea 309 / Southwest Asia, the Middle East and Africa 197 / Russia and Central Asia 15 / North America 62 / Central and South America 12 / China 68 / Other 2 / Products Petrochemicals 274 / Oil and Gas 152 / Power Generation, etc. 123 / Chemicals and Fertilizers 263 / Pharmaceuticals, Environment and Industrial Facilities 101 / Other 21 / Profit Not disclosed |
| Breakdown of Factors Affecting the Change | Operating CF Amount ¥-60 100 million / Factors Reversal of the positive result in the previous fiscal year / Investing CF Amount ¥63 100 million / Factors Decrease in time deposits / Financing CF Amount ¥-197 100 million / Factors Repayment of borrowings |
| Key KPIs | Indicator name Orders received / Value ¥1,065 100 million / Year on year against the same period last year -¥21.2 billion, Indicator name Orders received, including equity-method investments / Value ¥1,170 100 million / Year on year against the same period last year -¥247.1 billion, Indicator name Order backlog / Value ¥2,811 100 million / Year on year against the same period last year -¥46.4 billion, Indicator name Order backlog, including equity-method affiliates / Value ¥4,550 100 million / Year on year against the same period last year -¥158.9 billion, Indicator name Equity ratio / Value 20.0% / Year on year against the same period last year +3.3 percentage points, Indicator name Debt-to-equity ratio / Value 0.9 Times / Year on year against the same period last year -0.12x |
| Assumptions Underlying the Business Outlook | Exchange rate US$1=¥150 |
| Financial targets | ROE 12.9% (forecast for the fiscal year ending March 2027) / Debt-to-equity ratio 0.90x (actual as of September 2026) / Equity ratio 20.0% (actual as of September 2026) |
| Annual Dividend | Annual ¥25 / Interim ¥0 / End of period ¥25 |
| Orders received and order backlog | Orders received ¥1,065 100 million / Order backlog ¥2,811 100 million / Orders received, including equity-method investments ¥1,170 100 million / Order backlog, including equity-method affiliates ¥4,550 100 million |
Items this document does not state (12)
Results for the three months of the current quarterUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&ANew initiatives
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The specific reasons for the improvement in earnings were not explained. For cash flow, the company attributed the decrease in operating cash flow to the “reversal of the positive result in the previous fiscal year,” the increase in investing cash flow to a “decrease in time deposits,” and the decrease in financing cash flow to “repayment of borrowings.”
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.